Seroba Life Sciences

What is Seroba Life Sciences?

Seroba Life Sciences is a European venture capital firm based in Dublin, Ireland, focusing on the life sciences sector.

With an expertise in equity investments, Seroba positions itself as a key player in supporting early to late-stage companies in the biotechnology, health technology and fitness, medical devices and hospital services, healthcare and wellness, life sciences, consumer, and pharmaceutical and medicine industries, including ventures that are woman-focused.

The fund typically invests between €100,000 and €5,000,000, with an investment sweet spot of around €1,500,000. Seroba showcases a broad specialization, engaging in seed, startup, early-stage, expansion, later-stage, Series A, and Series B financing rounds. The firm prides itself on making a tangible impact on society by investing in life-changing innovations and working closely with entrepreneurs to build world-class businesses around extraordinary scientific developments.

Their approach is characterized by complementing skill sets with deep investment and operational industry experience.

With assets under management totaling €195,000,000, Seroba is a venture capital fund that stands out for its commitment to value creation through backing winning innovations, as exemplified by their investment in companies such as Coave Therapeutics and their participation in Deciphex's Series C financing.

These activities underscore their active role in addressing global challenges such as the acute pathology crisis and advancing genetic medicines. Seroba maintains a comprehensive portfolio of outstanding companies and leverages its team's significant industry expertise to foster the growth and success of its investments.

What they say:

We are a firm dedicated to pioneering health innovations in life sciences.

What we look for: We invest in breakthrough healthcare technologies and life sciences.